There are 50 papers on methylmalonic acid in aging research: 5 trials and 35 observational studies in people, 1 in animals, 7 reviews.
1 new paper in 30 daysSee all 61 papers on methylmalonic acid
“MMA showed a significant association with CKM stages (odds ratio, 3.73 [95% CI, 3.47-4.01]) after adjustment for multivariate covariates.”
- Human trial5
- Humans35
- Animals1
Interventions
2Methylcobalamin
downin humans1
1 study
Methylcobalamin
downin humans1
Methylcobalamin decreases methylmalonic acid in humans.
Human trialDiabetic non-demented outpatients with borderline vitamin B12 status; compared with placeboserum1000 μg once daily9 and 27 monthsn = 271
Multivitamin
downin humans1
1 study
Multivitamin
downin humans1
Multivitamin decreases methylmalonic acid in humans.
Human trial6 monthsfemalesn = 220
Effects
2Cognitive function
mediatesin humans3
3 studies
Cognitive function
mediatesin humans3
Methylmalonic acid is linked with cognitive function in humans (mediating 13.33% of the relationship between renal function and CF) (13.33%, β = 0.000949, 95%CI: 0.000419-0.002463, p = 0.002).
Humansmediating 13.33% of the relationship between renal function and CFn = 2,437
Methylmalonic acid is linked with cognitive function in humans (between the high-DLM group and DSST and global cognitive score) (mediated proportions of 3.8%, and 4.1%).
Humansbetween the high-DLM group and DSST and global cognitive scoren = 2,312
Methylmalonic acid is linked with cognitive function in periodontitis-cognitive function link (mediated 11.7% and 5.8%).
Humansin periodontitis-cognitive function linkn = 1,883
Distant metastases
no changein humans1
1 study
Distant metastases
no changein humans1
Methylmalonic acid was not clearly linked with distant metastases in humans (matched pairs, adjusted for kidney function and age) (P = 0.19).
Humansmatched pairs, adjusted for kidney function and age5 years
Upstream
2Breast cancer
downin mice1
1 study
Breast cancer
downin mice1
Breast cancer decreases methylmalonic acid in mice (tumor-bearing vs group without tumors) (P = 0.03).
Animalstumor-bearing vs group without tumors
Periodontitis
upin humans1
1 study
Periodontitis
upin humans1
Periodontitis is linked with higher methylmalonic acid in humans.
Humansn = 1,883
Associations
21Mortality
upin humans4HR 1.55–2.17
4 studies
Mortality
upin humans4HR 1.55–2.17
Methylmalonic acid is associated with mortality in humans (Hyperlipidemia; fully adjusted analysis) (Adjusted HR 1.55 (95% CI 1.30–1.84) per unit increase in ln-transformed MMA).
HumansHyperlipidemia; fully adjusted analysisserumMedian follow-up of 6.8 years
Methylmalonic acid is associated with mortality in humans (highest versus lowest MMA quartile) (HR 2.03 (95% CI, 1.78-2.30)).
Humanshighest versus lowest MMA quartilemedian follow-up of 102 months
Methylmalonic acid is linked with a higher risk of mortality in low muscle mass population, after full covariate adjustment (HR = 2.17, 95% CI: 1.64-2.89, p < 0.001).
Humansin low muscle mass population, after full covariate adjustment
Methylmalonic acid is linked with a higher risk of mortality in humans.
Humansn = 8,343
Knee extensor strength
downin humans2
2 studies
Knee extensor strength
downin humans2
Methylmalonic acid is associated with knee extensor strength in humans (β = -7.53, P = 0.015).
Humans
Methylmalonic acid is associated with knee extensor strength in humans.
Review
Bone mineral density
downin humans2
2 studies
Bone mineral density
downin humans2
Methylmalonic acid is associated with bone mineral density in humans (full population) (β = -0.01, P = 0.018).
Humansfull population
Methylmalonic acid is associated with bone mineral density in humans.
Reviewbone
Frailty
upin humans2
2 studies
Frailty
upin humans2
Methylmalonic acid is associated with frailty in humans (older patients with early-stage breast cancer) (260 nmol/L vs. 188 nmol/L, P = 0.0004).
Humansolder patients with early-stage breast cancerserumfemalesn = 119
Frailty is associated with methylmalonic acid in humans (ρ = 0.25, P = 0.00013).
Humansn = 238
Older age
upin humans2
2 studies
Older age
upin humans2
Methylmalonic acid is associated with older age in humans.
Humansserum
Methylmalonic acid is associated with older age in humans.
Humansserum
Osteoporosis
upin humans1
1 study
Osteoporosis
upin humans1
Methylmalonic acid is associated with osteoporosis in humans.
Reviewbone
Hypertension
upin humans1
1 study
Hypertension
upin humans1
Methylmalonic acid is linked with a higher risk of hypertension in humans (MMA ≥ 244 nmol/L compared to ≤ 133 nmol/L).
HumansMMA ≥ 244 nmol/L compared to ≤ 133 nmol/Ln = 2,153
Cardiovascular mortality
upin humans1HR 2.31
1 study
Cardiovascular mortality
upin humans1HR 2.31
Methylmalonic acid is associated with cardiovascular mortality in humans (highest versus lowest MMA quartile) (HR 2.31 (95% CI, 1.81-2.95)).
Humanshighest versus lowest MMA quartilemedian follow-up of 102 months
Cardiovascular-kidney-metabolic syndrome stage
upin humans1OR 3.73
1 study
Cardiovascular-kidney-metabolic syndrome stage
upin humans1OR 3.73
Methylmalonic acid is associated with cardiovascular-kidney-metabolic syndrome stage in humans after adjustment for multivariate covariates (OR 3.73 (95% CI, 3.47-4.01)).
Humansafter adjustment for multivariate covariates
Alpha-Klotho
downin humans1OR 0.8
1 study
Alpha-Klotho
downin humans1OR 0.8
Methylmalonic acid is associated with alpha-Klotho in humans (highest (≥250 nmol/L) versus lowest (<120 nmol/L) MMA quartile, adjusted odds ratios) (adjusted OR 0.80 (95% CI 0.68 to 0.94) for Q4 versus Q1).
Humanshighest (≥250 nmol/L) versus lowest (<120 nmol/L) MMA quartile, adjusted odds ratiosn = 5,216